Clinical Trials on Papulosquamous Skin Disease

Total 378315 results

Bayer

Terminated

BAY1003803 Single and Multiple Dose Escalation, Safety, Tolerability and Pharmacokinetics Study

Psoriasis

Germany
Janssen Research & Development, LLC

Completed

Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis

Psoriasis

United States
Prism Pharma Co., Ltd.

Completed

Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test

Psoriasis

Germany
Janssen Inc.

Completed

A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type Psoriasis (X-PLORE)

Psoriasis

United States, Poland, Canada, Belgium, Germany
Bausch Health Americas, Inc.

Completed

A Bioequivalence Study Comparing a Single 1.5mL Dose of Brodalumab vs. Two Doses (1.0mL + 0.5mL) of Brodalumab

Psoriasis

United States
Bausch Health Americas, Inc.

Completed

Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque Psoriasis

Psoriasis

United States
GlaxoSmithKline

Completed

A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.

Psoriasis

United Kingdom
Pfizer

Completed

AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis

Psoriasis

United States
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED) (TIPS)

Psoriasis
Chengdu PLA General Hospital

Unknown

Safety and Efficacy of Etanercept in Patients With Psoriasis

Psoriasis

China
Tufts Medical Center

Completed

Use of Localized NB-UVB (Levia®) in the Treatment of Plaque-psoriasis

Psoriasis

United States
Tufts Medical Center
Immune Control

Completed

Fluphenazine Hydrochloride for Psoriasis (FP-CL2)

Psoriasis

United States
Amgen

Completed

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis (REFINE)

Psoriasis

Canada
Pfizer

Completed

Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis (AN2728PSR203)

Psoriasis

Mexico
Pfizer

Completed

Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis

Psoriasis

Mexico
Pfizer

Completed

Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis

Psoriasis

Mexico
China Medical University Hospital

Completed

A Study of Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type Psoriasis

Psoriasis

Taiwan
Stiefel, a GSK Company
GlaxoSmithKline

Completed

The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis

Psoriasis

United States
Almirall, S.A.

Completed

Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008 (LAS41008)

Psoriasis

United Kingdom
Universitaire Ziekenhuizen KU Leuven
Pfizer

Completed

An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients (DERM)

Psoriasis
Centre Hospitalier Universitaire de Nice
Pfizer; Fotofinder

Completed

PASIMAT: Automatic Measure of PASI (PASIMAT)

Psoriasis
MedDerm Associates

Terminated

Study to Evaluate Broadlumab vs Placebo and Ustekinumab (AMAGINE-3)

Psoriasis

United States
Rockefeller University

Completed

Comparative Analysis of Small and Large Plaque Psoriasis

Psoriasis

United States
Amgen

Completed

AMG 714 20060349 Multiple Dose Study in Moderate to Severe Psoriasis Subjects

Psoriasis
Merck Sharp & Dohme LLC
Centocor, Inc.

Completed

Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900)

Psoriasis
Fundación Pública Andaluza Progreso y Salud

Completed

Etanercept Survival in Elderly Population

Psoriasis

Spain
Almirall, S.A.

Completed

A Intra-individual Comparison to Investigate the Efficacy and the Safety of LAS41004 Formulation in Mild to Moderate Psoriasis (Left/Right)

Psoriasis

Germany
Almirall, S.A.

Completed

Study to Investigate Dose-related Efficacy of LAS41004 in the Treatment of Psoriasis

Psoriasis

Germany
Almirall, S.A.

Completed

Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis

Psoriasis

Germany
Centocor, Inc.

Completed

A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis

Psoriasis
Wayne State University
Abbott

Terminated

Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque Psoriasis

Psoriasis
University of Aberdeen
NHS Grampian

Completed

Regulatory T-cells in Psoriasis Patients as Targets for Therapy

Psoriasis

United Kingdom
University of Rochester
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Withdrawn

The Effectiveness of Lower Cyclosporine Doses for Psoriasis

Psoriasis

United States
Innovaderm Research Inc.
Amgen

Completed

Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments

Psoriasis

Canada
Xijing Hospital
Henan Provincial People's Hospital; The First Affiliated Hospital of Dalian...

Completed

Efficacy and Safety Study of Total Glucosides of Paeony Combined With Acitretin to Treat Psoriasis

Psoriasis

China
Boehringer Ingelheim

Completed

Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe Psoriasis

Psoriasis

Germany, Denmark, Belgium, Canada, France, Sweden, Netherlands, Finland, Spain, United Kingdom
Maruho North America Inc.

Completed

Study to Evaluate the Pharmacokinetics and the Safety of M518101 in Plaque Psoriasis Patients

Psoriasis

United States
Amgen
Immunex Corporation

Completed

The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis

Psoriasis
Genentech, Inc.

Completed

A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g

Psoriasis
Genentech, Inc.

Completed

A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies

Psoriasis
Annesofie Faurschou
University of Copenhagen

Completed

The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis

Psoriasis

Denmark
Centocor, Inc.

Completed

An Efficacy and Safety Study of CNTO 1275 Compared to Etanercept in Patients With Plaque Psoriasis

Psoriasis
Kyowa Kirin Co., Ltd.

Completed

A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis

Psoriasis

Japan
Provectus Pharmaceuticals

Completed

Randomized Study of PH-10 for Psoriasis

Psoriasis

United States
University Hospital, Gentofte, Copenhagen
Pfizer; The Michaelsen Foundation

Unknown

TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis

Psoriasis

Denmark, Sweden
Sheba Medical Center

Unknown

The Effect of Alga Dunaliella Bardawil on Psoriasis

Psoriasis

Israel
Pfizer

Completed

Evaluation of Etanercept in Patients With Plaque Psoriasis After Stopping Ciclosporin Therapy

Psoriasis
Medical University of Graz

Completed

Primary UVB-311nm and Adalimumab in Psoriasis Patients

Psoriasis

Austria
Medical University of Graz

Completed

Ustekinumab Plus UVB-311nm in Psoriasis

Psoriasis

Austria
University of the Philippines
Philippine Dermatological Society

Completed

A Survey on the Role and Benefits of Online Social Networks on Filipino Patients With Psoriasis

Psoriasis

3

Subscribe